Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-20
2011-10-11
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S182000, C548S184000, C544S328000, C544S406000, C546S269700, C514S255050, C514S256000, C514S336000, C514S365000, C514S369000
Reexamination Certificate
active
08034954
ABSTRACT:
The present invention provides novel calcium channel antagonists, and methods of treating disease sates using the novel antagonists.
REFERENCES:
patent: 4210762 (1980-07-01), Howe
patent: 6335327 (2002-01-01), Ogawa et al.
patent: 6355635 (2002-03-01), Elliott et al.
patent: 6706717 (2004-03-01), Barrish et al.
patent: 2003/0199523 (2003-10-01), Snutch
patent: 2004/0038990 (2004-02-01), Guba et al.
patent: 2005/0038073 (2005-02-01), Neidhart et al.
patent: 2005/0038089 (2005-02-01), Neidhart et al.
patent: 19858192 (2000-06-01), None
patent: 1140921 (2003-04-01), None
patent: WO 98/03505 (1998-01-01), None
patent: WO 2005037825 (2005-04-01), None
patent: WO 2005/051932 (2005-06-01), None
patent: WO 2006/093247 (2006-09-01), None
Triggle, D. J., Biochemical Pharmacology, 74, 1-9, 2007.
Forlani et al., Gazzeta Chimica Italiana, 113(11-12), 807-810, 1983; CA 101: 130624,1984.
Foye et al., Journal of the Pharmaceutical Association, Scientific Edition, 45, 461-463, 1956; CA 51: 5538, 1957.
International search Report mailed on Aug. 18, 2008, for PCT Application No. PCT/US06/48722 filed on Dec. 20, 2006, 2 pages.
Lombardo, Louis J. et al., “Discovery ofN-(2-Chloro-6-methyl-phenyl)-2-(6-(4-(2- hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays,”J. Med. Chem. 47:6658-6661 (2004).
Todorovic, Slobodan M., “Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker,”Brain Research951:336-340 (2002).
Database Chemcats [Online], Chemical Abstracts Service, Columbus, Ohio, US; Sep. 10, 2002, XP002606612; retrieved from STN; Database accession No. 0026273110; * order number: T6775837 *.
Relevant portion of Supplementary European Search Report, Appln. No. EP 06847881.7, dated Oct. 25, 2010.
Fritch Paul Christopher
Pacofsky Gregory J.
Suto Mark J.
Balasubramanian Venkataraman
Icagen Inc.
Morgan & Lewis & Bockius, LLP
LandOfFree
Calcium channel antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium channel antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium channel antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282013